share

3-Phenylpropenoic Acid 7,8-Didehydro-4,5α-Epoxy-3-Methoxy-17-Methyl-6-Oxomorphinan-14-Yl Ester CAS NO 751-01-9


Unit Price:

CAS No.:751-01-9

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

3-Phenylpropenoic Acid 7,8-Didehydro-4,5α-Epoxy-3-Methoxy-17-Methyl-6-Oxomorphinan-14-Yl Ester is a high-purity, specialized pharmaceutical intermediate of significant interest in advanced research and development. This compound is critical for its role in the synthesis and study of complex morphinan-based molecules, offering a key building block for medicinal chemistry. It is primarily utilized by pharmaceutical R&D laboratories, academic research institutions, and fine chemical manufacturers focused on developing novel therapeutic agents and conducting pharmacological studies.

Application

  • Pharmaceutical Intermediate: A key precursor in the synthesis of complex opioid analogs and other morphinan-derived active pharmaceutical ingredients (APIs).
  • Medicinal Chemistry Research: Used as a scaffold or building block for structure-activity relationship (SAR) studies to develop new therapeutic compounds.
  • Reference Standard: Serves as a high-purity analytical standard for quality control and method development in pharmaceutical analysis.
  • Biochemical Research: Employed in pharmacological studies to investigate receptor binding and biochemical pathways related to the central nervous system.
  • Process Development: Utilized in the scale-up and optimization of synthetic routes for advanced pharmaceutical manufacturing.

Basic Information

Product Name 3-Phenylpropenoic Acid 7,8-Didehydro-4,5α-Epoxy-3-Methoxy-17-Methyl-6-Oxomorphinan-14-Yl Ester
CAS No. 751-01-9
Molecular Formula C28H27NO5
Molecular Weight 457.52 g/mol
Synonyms Oripavine 3-cinnamate; 3-Cinnamoyl-7,8-didehydro-4,5α-epoxy-3-methoxy-17-methylmorphinan-6-one; 3-Cinnamoyl-7,8-didehydro-4,5α-epoxy-3-methoxy-17-methyl-6-oxomorphinan; 3-Cinnamoyl-7,8-didehydro-4,5α-epoxy-3-methoxy-17-methylmorphinan-6-one; 3-Cinnamoyl-7,8-didehydro-4,5α-epoxy-3-methoxy-17-methyl-6-oxomorphinan; 3-Cinnamoyl-7,8-didehydro-4,5α-epoxy-3-methoxy-17-methylmorphinan-6-one; 3-Cinnamoyl-7,8-didehydro-4,5α-epoxy-3-methoxy-17-methyl-6-oxomorphinan; 3-Cinnamoyl-7,8-didehydro-4,5α-epoxy-3-methoxy-17-methylmorphinan-6-one
EINECS Contact for details

Quality Control

Our 3-Phenylpropenoic Acid 7,8-Didehydro-4,5α-Epoxy-3-Methoxy-17-Methyl-6-Oxomorphinan-14-Yl Ester is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC, NMR, and mass spectrometry, to ensure identity, purity, and consistency. Certificates of Analysis (COA) detailing all specifications are provided with every shipment to support your quality assurance and regulatory needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed after opening to prevent degradation from atmospheric moisture.

Specification

Item Specification
Appearance White to off-white crystalline powder
Identification (IR) Conforms to reference spectrum
Identification (HPLC) Retention time matches reference standard
Purity (HPLC) ≥ 98.0%
Water Content (KF) ≤ 1.0%
Residue on Ignition ≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.